Advertisement

Novavax, Inc. NVAX

Set alert

Price alert · NVAX

All alert types
10.08 USD -0.39 -3.72%

At close · Oct 30

10.01 -0.07 -0.73%

After hours · Oct 30, 6:56 PM ET

Bid
10.06 × 30
Ask
10.07 × 1
9.92 Day range 10.65
6.22 52-week range 12.82
YTD
+50.00%
1 year
+19.57%
Open
10.29
Prev close
10.47
Mkt cap
1.66B
Vol
4.06M
Avg vol
6.32M
EPS
-1.58
P/E
0.00
Div yield
0.00%
More statistics
Low
9.92
High
10.65
Forward P/E
-61.50
Beta
2.44
Short ratio
5.77
Inst. own
66.62%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
10.43
200-d avg
9.29
1y target
14.44

MAX chart

Chart tools
Interval

Events in this range
  • Aug 6, 2025Earnings: 0.62; estimate -0.07; surprise 985.71%
  • Nov 6, 2025Earnings: -1.25; estimate -1.08; surprise -15.74%
  • May 6, 2026Earnings: -0.06; estimate -0.25; surprise 76%
  • May 6, 2026Rating: TD Cowen · Hold → Hold
  • Aug 6, 2026Earnings: -0.32; estimate -0.37984; surprise 15.75%
  • Nov 5, 2026Earnings: —; estimate -0.34595; surprise —%
Signals (122)
NameDateAgo
SMA: BullishAug 1, 20263 months ago
SMA: BullishAug 1, 20263 months ago
SMA: BearishJul 1, 20264 months ago
SMA: BearishJul 1, 20264 months ago
SMA: BullishMay 1, 20266 months ago
SMA: BullishMay 1, 20266 months ago
SMA: BearishApr 1, 20267 months ago
SMA: BearishApr 1, 20267 months ago
SMA: BullishJan 1, 202610 months ago
SMA: BullishJan 1, 202610 months ago
SMA: BearishNov 1, 202512 months ago
SMA: BearishNov 1, 202512 months ago
SMA: BullishSep 1, 20251 year ago
SMA: BullishAug 1, 20251 year ago
SMA: BearishNov 1, 20241 year ago
SMA: BullishMay 1, 20242 years ago
MACD: Buy SignalOct 1, 20233 years ago
SMA: BearishJan 1, 20224 years ago
SMA: BearishDec 1, 20214 years ago
SMA: BullishNov 1, 20215 years ago
SMA: BearishOct 1, 20215 years ago
MACD: Sell SignalOct 1, 20215 years ago
SMA: BullishJun 1, 20215 years ago
SMA: BearishMay 1, 20215 years ago
RSI: OverboughtJan 1, 20215 years ago
RSI: OverboughtJun 1, 20206 years ago
SMA: BullishMay 1, 20206 years ago
SMA: BullishJan 1, 20206 years ago
MACD: Buy SignalDec 1, 20196 years ago
MACD: Sell SignalMay 1, 20197 years ago
SMA: BearishFeb 1, 20197 years ago
SMA: BearishFeb 1, 20197 years ago
SMA: BullishJan 1, 20197 years ago
SMA: BearishDec 1, 20187 years ago
SMA: BullishNov 1, 20188 years ago
SMA: BullishSep 1, 20188 years ago
SMA: BearishJun 1, 20188 years ago
SMA: BullishNov 1, 20179 years ago
MACD: Buy SignalNov 1, 20179 years ago
SMA: BearishSep 1, 201610 years ago
SMA: BearishSep 1, 201610 years ago
SMA: BullishJun 1, 201610 years ago
SMA: BullishJun 1, 201610 years ago
SMA: BearishJan 1, 201610 years ago
MACD: Sell SignalOct 1, 201511 years ago
SMA: BearishSep 1, 201511 years ago
RSI: OverboughtMay 1, 201511 years ago
RSI: OverboughtJan 1, 201511 years ago
SMA: BullishOct 1, 201412 years ago
MACD: Buy SignalOct 1, 201412 years ago
MACD: Sell SignalSep 1, 201412 years ago
SMA: BearishJul 1, 201412 years ago
RSI: OverboughtNov 1, 201313 years ago
SMA: BullishJun 1, 201313 years ago
SMA: BearishMay 1, 201313 years ago
SMA: BullishMar 1, 201313 years ago
SMA: BullishMar 1, 201313 years ago
SMA: BearishJan 1, 201313 years ago
SMA: BearishNov 1, 201214 years ago
SMA: BullishJul 1, 201214 years ago
MACD: Buy SignalJul 1, 201214 years ago
SMA: BullishJun 1, 201214 years ago
MACD: Sell SignalJul 1, 201115 years ago
SMA: BearishJun 1, 201115 years ago
SMA: BearishMay 1, 201115 years ago
SMA: BullishFeb 1, 201115 years ago
SMA: BullishFeb 1, 201115 years ago
MACD: Buy SignalFeb 1, 201115 years ago
SMA: BearishJan 1, 201115 years ago
SMA: BullishDec 1, 201015 years ago
SMA: BearishNov 1, 201016 years ago
SMA: BullishOct 1, 201016 years ago
SMA: BearishMay 1, 201016 years ago
SMA: BullishApr 1, 201016 years ago
MACD: Sell SignalFeb 1, 201016 years ago
SMA: BearishDec 1, 200916 years ago
SMA: BearishNov 1, 200917 years ago
SMA: BullishJun 1, 200917 years ago
SMA: BullishJun 1, 200917 years ago
MACD: Buy SignalJun 1, 200917 years ago
SMA: BearishMay 1, 200917 years ago
SMA: BullishApr 1, 200917 years ago
SMA: BearishOct 1, 200818 years ago
SMA: BullishSep 1, 200818 years ago
SMA: BearishJan 1, 200818 years ago
MACD: Sell SignalJan 1, 200818 years ago
SMA: BearishNov 1, 200719 years ago
MACD: Buy SignalOct 1, 200719 years ago
SMA: BullishSep 1, 200719 years ago
SMA: BullishSep 1, 200719 years ago
SMA: BearishFeb 1, 200719 years ago
MACD: Sell SignalFeb 1, 200719 years ago
SMA: BearishJul 1, 200620 years ago
SMA: BullishJan 1, 200620 years ago
SMA: BullishOct 1, 200521 years ago
MACD: Buy SignalOct 1, 200521 years ago
MACD: Sell SignalAug 1, 200422 years ago
SMA: BearishMar 1, 200422 years ago
SMA: BearishOct 1, 200323 years ago
SMA: BullishSep 1, 200323 years ago
MACD: Buy SignalJul 1, 200323 years ago
SMA: BullishFeb 1, 200323 years ago
SMA: BearishApr 1, 200224 years ago
MACD: Sell SignalFeb 1, 200224 years ago
SMA: BearishJan 1, 200224 years ago
RSI: OverboughtAug 1, 200125 years ago
SMA: BullishApr 1, 200125 years ago
SMA: BearishFeb 1, 200125 years ago
SMA: BullishNov 1, 200026 years ago
SMA: BearishOct 1, 200026 years ago
RSI: OverboughtFeb 1, 200026 years ago
SMA: BullishJul 1, 199927 years ago
SMA: BearishJun 1, 199927 years ago
SMA: BullishMay 1, 199927 years ago
SMA: BearishApr 1, 199927 years ago
SMA: BullishMar 1, 199927 years ago
MACD: Buy SignalMar 1, 199927 years ago
SMA: BullishFeb 1, 199927 years ago
SMA: BearishFeb 1, 199828 years ago
SMA: BullishDec 1, 199728 years ago
SMA: BearishNov 1, 199729 years ago
SMA: BullishJun 1, 199729 years ago

Key statistics

Market cap
1.66B
Enterprise value
1.30B
Trailing P/E
0.00
Forward P/E
-61.50
PEG ratio
1.32
Price / sales
4.02
Price / book
0.00
EPS (TTM)
-1.58
Beta
2.44
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-59.87%
Revenue (TTM)
413.80M
Revenue growth
-76.30%
Free cash flow
153.39M
Total cash
719.34M
Total debt
297.32M
Return on equity
0.00%
Shares outstanding
164.95M
Short % of float
28.89%
50-day average
10.43
200-day average
9.29

Analyst view

Consensus: buy

Buy
Price target (mean) 14.44 +43.3% upside
Target (low)
7.00
Target (mean)
14.44
Target (high)
25.00
Ratings (0m) 9 5 buy · 1 hold · 3 sell
  • Strong buy0
  • Buy5
  • Hold1
  • Sell1
  • Strong sell2

Next earnings

Nov 5, 2026

Expected Nov 5, 2026. Consensus EPS estimate -0.42.

Earnings history

Financials — quick view

All financials
NVAX Revenue — quarterly 56.70M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
NVAX Net income — quarterly -53.39M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
NVAX EPS — quarterly -0.32
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

NVAX recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 5, 2026Sep 30, 2026-0.34595———
Aug 6, 2026Jun 30, 2026-0.37984-0.32+0.06+15.75%
May 6, 2026Mar 31, 2026-0.25-0.06+0.19+76.00%
Feb 26, 2026Dec 31, 2025-0.660.11+0.77+116.67%
Nov 6, 2025Sep 30, 2025-1.08-1.25-0.17-15.74%
Aug 6, 2025Jun 30, 2025-0.070.62+0.69+985.71%

Upgrades / downgrades

NVAX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 15, 2026CitigroupmainSellSell
Jun 11, 2026BTIGreitBuyBuy
May 6, 2026TD CowenmainHoldHold
Feb 27, 2026HC Wainwright & Co.mainBuyBuy
Jan 20, 2026BTIGreitBuyBuy
Nov 18, 2025JP MorganmainUnderweightUnderweight

About Novavax, Inc.

Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Website
novavax.com

News

Your note

Sign in to keep a note on NVAX — it syncs with the Stock Master app.

Insider holders

NVAX insider holders
InsiderRelationLatest transactionDateShares held
ALTON GREGG HDirectorConversion of Exercise of derivative securityJun 17, 202647,685
CASEY MARK JOfficerConversion of Exercise of derivative securityMar 2, 202690,067
DOUGLAS RICHARD HDirectorConversion of Exercise of derivative securityJun 17, 202673,220
JACOBS JOHN CChief Executive OfficerConversion of Exercise of derivative securityMar 2, 2026225,680
KELLY JAMES PATRICKChief Financial OfficerConversion of Exercise of derivative securityMar 5, 2026130,599
MOTT DAVID MDirectorConversion of Exercise of derivative securityJun 17, 202679,770

Institution ownership

NVAX institution ownership
Holder% heldSharesValueReported
Blackrock Inc.8.46%13,946,881140.58MJun 29, 2026
Shah Capital Management7.38%12,173,481122.71MSep 29, 2026
State Street Corporation7.12%11,740,550118.34MJun 29, 2026
Vanguard Portfolio Management LLC4.61%7,607,99676.69MJun 29, 2026
Vanguard Capital Management LLC4.40%7,257,44973.16MJun 29, 2026
Sanofi4.17%6,880,48169.36MJun 29, 2026

Fund ownership

NVAX fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.15%5,197,17052.39MJun 29, 2026
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF2.79%4,603,62846.40MSep 29, 2026
iShares Trust-iShares Russell 2000 ETF2.41%3,971,98740.04MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.28%3,766,47037.97MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund1.31%2,163,10421.80MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund1.15%1,893,26019.08MJun 29, 2026
Advertisement